Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

DIRECTOR DEALINGS: Glaxo Executives Sell Shares, ADSs

17th Feb 2014 16:52

LONDON (Alliance News) - GlaxoSmithKline PLC Monday said a group of executives including Chief Executive Officer Simon Witty sold shares to meet tax liabilities at a price of GBP16.44 per share Thursday. Details are as follows. <table class="ai" cellspacing="0" cellp Read More

UK Dividends Calendar - Week Ahead

17th Feb 2014 16:16

DIRECTOR DEALINGS: GlaxoSmithKline Executives Share Awards Vest

14th Feb 2014 17:51

LONDON (Alliance News) - GlaxoSmithKline PLC Friday announced that a group of executives, including Chief Executive Officer Andrew Witty, had received shares after share options they had been awarded had vested. The following executives share options from the company's 2011 performa Read More

UK Dividends Calendar - Week Ahead

14th Feb 2014 16:03

UK MIDDAY BRIEFING: Lloyds Appoints TSB Chairman Ahead Of London Listing

14th Feb 2014 13:06

LONDON (Alliance News) - Lloyds Banking Group has appointed Will Samuel, a former Citi investment banker and adviser to one of the UK financial services regulators, as Chairman of TSB Bank, the bank it split out as a separate entity last year and is expected to list this year. Read More

UK BROKER RATINGS: Six Brokers Cut Tate & Lyle Price Target

14th Feb 2014 10:10

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning: ---------- FTSE 100 ---------- JPMORGAN RAISES LLOYDS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 95 (84) PENCE ---------- SOCGEN RAISES LLOYDS PRICE TARGE Read More

UK Dividends Calendar - Week Ahead

14th Feb 2014 06:29

UK Dividends Calendar - Week Ahead

13th Feb 2014 16:12

Vectura Says Performing In Line With Expectations

13th Feb 2014 12:00

LONDON (Alliance News) - Vectura Group PLC said Thursday that its performance in the period from October 1, 2013 to date had been in line with expectations. During the period Vectura's partner Sandoz saw marketing authorisation for AirFluSal Forspiro, an inhaler for asthma or Chronic Obstru Read More

UK Dividends Calendar - Week Ahead

13th Feb 2014 06:15

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares

12th Feb 2014 16:12

LONDON (Alliance News) - Glaxosmithkline PLC Wednesday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1631.63 pence Monday. Details are as follows. <b Read More

UK Dividends Calendar - Week Ahead

12th Feb 2014 16:12

DIRECTOR DEALINGS: Glaxo Divisional VP Exercises Options, Sells Shares

11th Feb 2014 16:36

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said Simon Bicknall, a divisional vice president, exercised options over 12,650 shares at an exercise price of GBP11.23 per share and sold the shares at GBP16 each Monday. Shares in the healthcare company were up 2.0% at 1,640.09 pence Tu Read More

DIRECTOR DEALINGS: GlaxoSmithKline CEO Gifts Shares

10th Feb 2014 19:21

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Chief Executive Officer Andrew Witty disposed of 1,800 shares as gifts in a series of transactions last Friday and on Monday. On Friday, Witty disposed of 50 shares as a gift and transferred 500 shares as a gift to one of his chi Read More

DIRECTOR DEALINGS: GlaxoSmithKline SVP Of Human Resources Buys Shares

10th Feb 2014 17:42

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Senior Vice President of Human Resources Claire Thomas bought 33.853 shares following the purchase of shares at 1651.50 pence per share through the re-investment of dividends Friday. Shares in GlaxoSmithKline closed down 0.7% at Read More

2nd UPDATE: AstraZeneca 2013 Results Down, Guidance Lowered

6th Feb 2014 13:31

LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read More

UK MIDDAY BRIEFING: Stocks Rising Again, Vodafone Leads FTSE 100

6th Feb 2014 13:18

LONDON (Alliance News) - The FTSE 100 is up for a second day Thursday as the rebound from the heavy losses in equity markets in the previous five days continues, with positive reports from the likes of Vodafone and Smith & Nephew helping London's blue-chip Read More

UK BROKER RATINGS: Credit Suisse Raises Reckitt To Outperform

6th Feb 2014 10:02

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon: ---------- FTSE 100 ---------- S&P CAPITAL IQ CUTS BG GROUP PRICE TARGET TO 1050 (1063) PENCE - 'SELL' ---------- CRED Read More

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open

6th Feb 2014 08:32

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%. Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit Read More

UK MORNING BRIEFING:

6th Feb 2014 08:31

FTSE 100 Latest

Value10,731.11

Change-12.24